The association between diabetes and migraine: a systematic review and meta-analysis
Abstract
Introduction
Diabetes and migraine are prevalent conditions that can significantly impact quality of life. Existing review suggests a possible connection between the two, though findings have varied.
Objective
This review aims to assess the prevalence and association between diabetes and migraine through a meta-analysis.
Methods
This approach was applied through searches in Scopus, WOS, PubMed, and Google Scholar. A PRISMA checklist was followed. The quality assessment was checked. The included studies investigated either migraine in diabetes patients or diabetes in migraine patients, with no restriction on age groups or timeframes. The meta-analyses were performed using Jamovi 2.3.28 and SPSS Version 28.
Results
Two groups of studies were analyzed. Group 1 (n= 8) assessed migraine prevalence in patients with diabetes. The overall migraine prevalence was 12% (95% CI: 6%- 17%). Type 2 diabetes had a migraine prevalence of 8% (95% CI: 1%- 15%), significantly affected by study demographics and duration of diabetes. Type 1 diabetes showed a lower migraine prevalence (1%). Odds ratios indicated a non- significant decrease in migraine prevalence among diabetes patients overall and a significant decrease for type 1 diabetes.
Group 2 (n= 17) examined diabetes prevalence among migraine patients. The overall odds ratio for diabetes prevalence was 0.86 (p< 0.05), indicating a significant decrease. Specific analyses showed a nearly significant reduction in diabetes prevalence for…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 17 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.